#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Idiopathic intracranial hypertension Pleomorphic leiomyosarcoma Amyotrophic lateral sclerosis gene carrier Acute lymphocytic leukaemia recurrent Small intestine neuroendocrine tumour Chronic myelomonocytic leukaemia Candida infection Adenocarcinoma gastric Mycobacterium abscessus infection Transitional cell carcinoma Mixed-type liposarcoma Conjunctivitis allergic Mastocytosis Plasma cell myeloma Mantle cell lymphoma stage IV More trials…

    Learn about Rare Diseases

    Basal cell naevus syndrome – Trials in Disease Glomerulonephritis membranoproliferative – Trials in Disease Methylmalonic acidaemia – Trials in Disease Rett syndrome – Life with Disease MELAS syndrome – Basic Information Niemann-Pick disease Phenylketonuria – Diagnostics Congenital nephrogenic diabetes insipidus – Diagnostics Urea cycle disorder – Treatment Cystic fibrosis lung – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Elritercept AAV9-CTNT-COBAG3 Palivizumab Poractant Alfa Dalteparin Sodium Isis 678354 Sodium Salt GS-248 Human Coagulation Factor X Zongertinib Etravirine Famotidine Masitinib ORX750 [18F]Alf-Nota-Octreotide VHB937 Macrogol 3350 Dapagliflozin Propanediol Izokibep SPY002 Ht-29-A More therapies…

    Learn about Your Condition

    Hypoaesthesia Generalised anxiety disorder Addison's disease Obesity Thromboangiitis obliterans Anal cancer metastatic Prinzmetal angina Polyneuropathy Thalassaemia Deafness traumatic Petit mal epilepsy Glomerulonephritis chronic Immune system disorder Myelofibrosis Neuroendocrine carcinoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University Multiprofile Hospital For Active Treatment…

University Multiprofile Hospital For Active Treatment Saint Georgi EAD

Bulevard Vasil Aprilov 15a, Plovdiv, 4002, Bulgaria

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Linaclotide for Treating Functional Constipation in Children Aged 6 Months to Less Than 2 Years

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Constipation
    Investigated Drugs:
    • Linaclotide
    Bulgaria Croatia Germany Hungary

  • Long-Term Study on Aflibercept for Retinopathy of Prematurity in Infants

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Retinopathy of prematurity
    Investigated Drugs:
    • Aflibercept
    Belgium Bulgaria Czechia Greece Italy Portugal +4

  • Study on the Effectiveness and Safety of Selinexor and Ruxolitinib for Patients with Myelofibrosis Who Have Not Received Prior Treatment

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Aprepitant
    • Ondansetron
    • Selinexor
    Belgium Bulgaria Czechia Denmark France Germany +7

  • Study on the Safety and Effectiveness of Tafasitamab and Lenalidomide for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-Hodgkin’s lymphoma
    Investigated Drugs:
    • Lenalidomide
    • Tafasitamab
    Bulgaria Croatia Czechia Denmark Finland Hungary +4

  • Study Comparing Obinutuzumab and Venetoclax with Obinutuzumab and Chlorambucil for Untreated Chronic Lymphocytic Leukemia Patients with Other Health Conditions

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • Chlorambucil
    • Rasburicase
    • Obinutuzumab
    Austria Bulgaria Croatia Denmark Estonia France +5

  • Study on Deucravacitinib for Patients with Active Psoriatic Arthritis New to Biologic Treatments

    Not recruiting

    3 1
    Investigated Diseases:
    • Psoriatic arthropathy
    Investigated Drugs:
    • Deucravacitinib
    Bulgaria Czechia Finland France Hungary Ireland +4

  • Study on Andexanet Alfa for Patients on Factor Xa Inhibitors (Apixaban, Rivaroxaban, Edoxaban) Needing Urgent Surgery to Reduce Bleeding Risk

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Aminocaproic Acid
    • Blood And Related Products
    • Etamsylate
    Austria Belgium Bulgaria Czechia Denmark Estonia +13

  • Study to Compare Mezigdomide, Carfilzomib, and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Carfilzomib
    • Dexamethasone
    • Mezigdomide
    Austria Bulgaria Denmark Germany Greece Hungary +5

  • Study Comparing Upadacitinib, Placebo, and Adalimumab for Patients with Moderate to Severe Rheumatoid Arthritis on Stable Methotrexate Treatment

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Adalimumab
    • Upadacitinib
    Belgium Bulgaria Croatia Czechia Estonia France +11

  • Study on REGN9933 for Preventing Blood Clots in Adults After Knee Replacement Surgery

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Embolism
    Investigated Drugs:
    • Regn9933
    • Apixaban
    • Enoxaparin Sodium
    Belgium Bulgaria Hungary Latvia Lithuania Poland
Previous Page
1 … 16 17 18 19 20
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!